Biological Age Predicts Dementia; APOE4 and Tau Patterns; AI and MS Brain Changes

Derick Alison
Derick Alison
2 Min Read

Advanced biological age calculated from clinical biomarkers predicted risks of dementia or stroke, U.K. Biobank data showed. (Journal of Neurology, Neurosurgery, and Psychiatry)

Carriers of APOE4 showed earlier amyloid-induced tau spreading. (JAMA Neurology)

A single-center study found no evidence of ongoing viral replication, immune activation, or central nervous system injury in cerebrospinal fluid in patients with long COVID cognitive problems. (Journal of Infectious Diseases)

Changing or combining advanced Parkinson’s therapies like deep brain stimulation and pump therapies was associated with an improvement in motor scores or subjective symptom reporting. (Neurology)

Women with a stroke history thought they would receive inadequate emergency department care based on their gender or race or ethnicity, survey data showed. (Stroke)

Retina pathology may help screen individuals for Alzheimer’s risk or monitor disease progression, but standards need to be harmonized. (Alzheimer’s & Dementia)

A gene therapy strategy selectively manipulated Parkinson’s-affected circuitry and affected motor symptoms in rodent and primate models of Parkinson’s disease. (Cell)

A clinically integrated AI-based MRI tool showed promise in detecting brain changes in multiple sclerosis. (NPJ Digital Medicine)

Cognitive behavioral therapy can significantly lower fatigue, functional impairment, and physical limitations in myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), a meta-analysis suggested. (Psychological Medicine)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more. Follow

Source link

Share this Article
Leave a comment
adbanner